Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes

Title: Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes
Authors: Patel, Rachel; Crabtree, Thomas S.J.; Taylor, Nicola; Langeland, Linn; Gazis, Anastasios (Tasso); Mendis, Buddhike; Wilmot, Emma G.; Idris, Iskandar
Publisher Information: Wiley
Publication Year: 2022
Collection: University of Nottingham: Repository@Nottingham
Subject Terms: Endocrinology; Diabetes and Metabolism; Internal Medicine
Description: Aims: The use of do-it-yourself artificial pancreas systems (DIYAPS) among people with type 1 diabetes is increasing. At present, it is unclear how DIYAPS compares with other technologies such as FreeStyle Libre (FSL) and continuous subcutaneous insulin infusion (CSII). The aim of this analysis is to compare safety, effectiveness and quality-of-life outcomes of DIYAPS use with the addition of FSL to CSII. Method: Data from two large UK hospitals were extracted from the Association of British Clinical Diabetologists (ABCD) DIYAPS and FSL audits. Outcomes included HbA1c, glucose TBR (time-below-range), TIR (time-in-range), Diabetes Distress Score (DDS), and Gold hypoglycaemia score. Any adverse events were noted. Changes at follow-up were assessed using paired t-tests and ANOVA in Stata; TIR/TBR at follow-up assessed using unpaired t-tests; chi-square tests assessed the change in frequency of health utilisation (e.g. hospital admissions). Results: DIYAPS (n=35) and FSL+CSII (n=149) users, with median follow-up duration of 1.4 (IQR 0.8–2.1) and 1.3 (IQR 0.7–1.8) years, respectively, were included. HbA1c with DIYAPS use changed by −10mmol/mol [0.9%] (p
Document Type: article in journal/newspaper
Language: English
Relation: https://nottingham-repository.worktribe.com/output/7223670; Diabetic Medicine; Volume 39; Issue 5
DOI: 10.1111/dme.14793
Availability: https://doi.org/10.1111/dme.14793; https://nottingham-repository.worktribe.com/file/7223670/1/DIY%20FSL%20RV3%20V4%20Clean; https://nottingham-repository.worktribe.com/output/7223670
Rights: openAccess
Accession Number: edsbas.80AA96C
Database: BASE